Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes.
about
Clinical review: Diabetes in the adolescent: transitional issuesInvestigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction.Increasing incidence of pediatric type 1 diabetes mellitus in Southeastern Wisconsin: relationship with body weight at diagnosis.Anti-inflammatory properties of C-Peptide.Self-reported history of overweight and its relationship to disordered eating in adolescent girls with Type 1 diabetes.The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study.Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes.Prevalence of obesity was related to HLA-DQ in 2-4-year-old children at genetic risk for type 1 diabetes.Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled studyMost youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelinesComparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes.Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy.Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes.A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial.Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it wasSurrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes.Insulin resistance and associated factors in patients with Type 1 Diabetes.Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.Obesity and youth diabetes: distinguishing characteristics between islet cell antibody positive vs. negative patients over time.Growth differences between North American and European children at risk for type 1 diabetesDevelopment and validation of the type 1 diabetes nutrition knowledge survey.Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.Cohort profile: the German Diabetes Study (GDS).Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond.Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes.Weight-loss practices and weight-related issues among youth with type 1 or type 2 diabetes.Dyslipidemia in youth with diabetes: to treat or not to treat?Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol studyOverweight among children and adolescent with type I diabetes mellitus: prevalence and associated factors.Relationships among parent and youth healthful eating attitudes and youth dietary intake in a cross-sectional study of youth with type 1 diabetes.Body mass index and retinopathy in type 1 diabetic patients.Multiple indicators of poor diet quality in children and adolescents with type 1 diabetes are associated with higher body mass index percentile but not glycemic control.Type 2 diabetes in childhood: clinical characteristics and role of β-cell autoimmunity.The potential role of glutamate in the current diabetes epidemic.Incidence of type 1 and type 2 diabetes in youth in the U.S. Virgin Islands, 2001-2010.Progression of β-cell dysfunction in obese youth.Overweight and obesity in youth with type 1 diabetesSurgical treatment of medically refractory gastroparesis in the morbidly obese.
P2860
Q30219892-64F93213-36C2-45E0-981E-8806829DDA89Q30500186-A252F8EC-533A-44E9-AC03-EA8B7083CF3CQ33499699-299DECE2-1836-48E5-A58D-93DAD1B86C7DQ33682573-F78E07ED-0E94-4FFC-B6E9-690F322905D1Q33735324-F3A5F8C3-DB4A-4AA4-AEB6-87A6E1334804Q34084523-24609306-13E6-4DC7-9BE3-984EFE6BDC20Q34256404-75C58D09-95E4-48DA-8A21-2328C1A4CC6CQ34288222-0B809ACE-DB74-42CB-BD18-8024CFC145E5Q34288242-76465D9D-1422-42BB-BE9A-A0D86AEFDE53Q34557730-886288BB-8651-4C66-B48C-8DBB7F73F042Q34610273-C6741834-5B31-4198-BA08-CE8607816A3AQ34620649-C43E1200-79A4-40F5-A653-F537576C5E4DQ34762316-079268DD-9B91-4A2E-A449-3EC7AF7C0CE3Q34810963-A697C722-2272-4B9D-9E84-C3FFE1C1431DQ34921545-CFA67F61-B98D-4328-B59E-D787EB454148Q35033592-C3A08DF9-9248-4562-8A20-DCFF5DA4E974Q35493180-1D6344B5-78D8-4EDB-B5AF-14547471F297Q35559139-30A3D0F9-1060-4B4D-8FF8-50CA72699107Q35651511-A95BD531-9B8D-41B2-B362-DBA53F4D003EQ35689171-01767816-F846-426A-AD83-CFF5FB54DEF0Q35911190-274AA90D-2530-4F2F-B278-A58CAC015FE4Q36109120-9113AE72-A4D4-4581-BAD3-745D3B86E140Q36152957-BC7FE011-59DB-4540-B9EC-86A1A965CA6AQ36311567-53EC0096-DD6B-4FF4-B5F1-5F81058582D5Q36774677-BF8B5C58-4290-4BFA-84AC-2437818CAA6EQ36969372-BADE8A65-CAE4-47E8-A5B3-9F1C273D711DQ36971945-6BA53EE5-B9DA-467E-A715-398470E1EA27Q36975623-7A83803A-F9E4-476B-B0B8-C4D8BF46D937Q36977819-7A455520-661B-4C0C-8A59-E687011F9CD0Q36988877-F5872F16-9107-428C-8736-81CD0A1DDAD0Q37099937-88D4348A-DD16-4F73-9680-88F6DF8073ABQ37308076-3B181B7A-1204-4410-9B48-2149B007CE50Q37628516-E9D06CC6-241D-4CFC-A019-374BBD9858D5Q37701130-90CD993C-F750-4F11-8651-020A4FA5E0AAQ37964530-64AF7555-6F52-4F06-854C-7863ECEAF1D4Q37973276-A81E1D39-1C3F-4E7F-887F-159EBA080FFCQ38038338-30FCCE7F-1A3F-4B18-A7FB-698E11E118AFQ38062439-AA9CDAA2-A056-474B-BFDD-E8629E508452Q38217367-CE1DB541-AC9A-4434-A120-726CB432C36BQ38321408-25ABCBB4-E24F-4C50-B3DC-861FCFA182D7
P2860
Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Changing prevalence of overwei ...... t of insulin-treated diabetes.
@ast
Changing prevalence of overwei ...... t of insulin-treated diabetes.
@en
type
label
Changing prevalence of overwei ...... t of insulin-treated diabetes.
@ast
Changing prevalence of overwei ...... t of insulin-treated diabetes.
@en
prefLabel
Changing prevalence of overwei ...... t of insulin-treated diabetes.
@ast
Changing prevalence of overwei ...... t of insulin-treated diabetes.
@en
P2093
P921
P1433
P1476
Changing prevalence of overwei ...... t of insulin-treated diabetes.
@en
P2093
Dorothy J Becker
Ingrid M Libman
Massimo Pietropaolo
Ronald E LaPorte
Silva A Arslanian
P304
P356
10.2337/DIACARE.26.10.2871
P407
P577
2003-10-01T00:00:00Z